Cloud evidence for your next healthcare security review.
One focused monthly offer for US healthcare software businesses operating supported AWS infrastructure.
Votexia Cloud Evidence
USD 999.00 / month
Planned monthly offer. Paid activation is not yet available. Explore a synthetic example before deciding whether it fits your review.
- Up to 3 defined AWS account connections and 20 internal seats.
- Authorized independent reviewer read/download access.
- Selected cloud-control observations, findings and verifiable evidence exports.
- Three-year ordinary-history reference, subject to the final supported retention and archive terms.
- Bounded product onboarding and limited, best-effort support.
The exact supported checks, regions, resource limits and collection schedule will be stated before purchase. This supports selected technical evidence work; it does not certify compliance or guarantee an audit outcome.
Applicable taxes are shown before payment. Customer cloud-provider charges are separate. No annual offer, standing launch discount or automatic public free trial is offered initially.
Before you purchase
Can I cancel renewal?
The planned monthly terms stop renewal and retain paid access through the confirmed period end. A full guarantee refund, account closure and privacy deletion have distinct consequences.
How does the initial-payment guarantee work?
Requests received within fourteen consecutive days of the first successful paid subscription invoice qualify under the initial guarantee. Ordinary in-scope use, exports and reviewer access do not end eligibility. Renewals do not restart it. Read the proposed refund terms.
Can I evaluate the workflow first?
Yes. Start with the synthetic demonstration; no customer cloud connection is needed for that discussion.
What about a BAA?
Where the actual processing role requires a BAA, it must be properly executed before that processing. It is not a premium upgrade. PHI is prohibited; the current legal documents remain drafts.
Do you have a referral program?
We are preparing separate eligible adviser referrals and unpaid independent reviewer participation. Explore the referral program.